|
1
|
Osada H and Takahashi T: Genetic
alterations of multiple tumor suppressors and oncogenes in the
carcinogenesis and progression of lung cancer. Oncogene.
21:7421–7434. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carneiro JG, Couto PG, Bastos-Rodrigues L,
Bicalho MA, Vidigal PV, Vilhena A, Amaral NF, Bale AE, Friedman E
and De Marco L: Spectrum of somatic EGFR, KRAS, BRAF, PTEN
mutations and TTF-1 expression in Brazilian lung cancer patients.
Genet Res (Camb). 96:e0022014.PubMed/NCBI
|
|
3
|
Zöchbauer-Müller S, Fong KM, Virmani AK,
Geradts J, Gazdar AF and Minna JD: Aberrant promoter methylation of
multiple genes in non-small cell lung cancers. Cancer Res.
61:249–255. 2001.PubMed/NCBI
|
|
4
|
Esteller M, Sanchez-Cespedes M, Rosell R,
Sidransky D, Baylin SB and Herman JG: Detection of aberrant
promoter hypermethylation of tumor suppressor genes in serum DNA
from non-small cell lung cancer patients. Cancer Res. 59:67–70.
1999.PubMed/NCBI
|
|
5
|
Kocaturk CI, Gunluoglu MZ, Cansever L,
Demir A, Cinar U, Dincer SI and Bedirhan MA: Survival and
prognostic factors in surgically resected synchronous multiple
primary lung cancers. Eur J Cardiothorac Surg. 39:160–166. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boeri M, Verri C, Conte D, Roz L, Modena
P, Facchinetti F, Calabrò E, Croce CM, Pastorino U and Sozzi G:
MicroRNA signatures in tissues and plasma predict development and
prognosis of computed tomography detected lung cancer. Proc Natl
Acad Sci USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang CJ, Nguyen PN, Choo KB, Sugii S, Wee
K, Cheong SK and Kamarul T: Frequent co-expression of miRNA-5p and
−3p species and cross-targeting in induced pluripotent stem cells.
Int J Med Sci. 11:824–833. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu
Y, Chen Y, Xu L, Zen K, Zhang C, et al: Serum microRNA signatures
identified in a genome-wide serum microRNA expression profiling
predict survival of non-small-cell lung cancer. J Clin Oncol.
28:1721–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu K, Chen Z, Qin C and Song X: miR-7
inhibits colorectal cancer cell proliferation and induces apoptosis
by targeting XRCC2. Onco Targets Ther. 7:325–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Li Y, Liu Y, Xie P, Li F and Li G:
PAX6, a novel target of microRNA-7, promotes cellular proliferation
and invasion in human colorectal cancer cells. Dig Dis Sci.
59:598–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W,
Wu Z, Chen T, Wu W, Lobie PE, et al: MicroRNA-7 inhibits
epithelial-to-mesenchymal transition and metastasis of breast
cancer cells via targeting FAK expression. PLoS One. 7:e415232012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chou YT, Lin HH, Lien YC, Wang YH, Hong
CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, et al: EGFR promotes
lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc
pathway that targets the Ets2 transcriptional repressor ERF. Cancer
Res. 70:8822–8831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X,
Qian J, Gu J, Chang L, Ge D and Chu Y: PA28gamma emerges as a novel
functional target of tumour suppressor microRNA-7 in non-small-cell
lung cancer. Br J Cancer. 110:353–362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rai K, Takigawa N, Ito S, Kashihara H,
Ichihara E, Yasuda T, Shimizu K, Tanimoto M and Kiura K: Liposomal
delivery of MicroRNA-7-expressing plasmid overcomes epidermal
growth factor receptor tyrosine kinase inhibitor-resistance in lung
cancer cells. Mol Cancer Ther. 10:1720–1727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G,
Luo J and Ren T: microRNA-7-regulated TLR9 signaling-enhanced
growth and metastatic potential of human lung cancer cells by
altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt
pathway. Mol Biol Cell. 24:42–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li YJ, Wang CH, Zhou Y, Liao ZY, Zhu SF,
Hu Y, Chen C, Luo JM, Wen ZK and Xu L: TLR9 signaling repressed
tumor suppressor miR-7 expression through up-regulation of HuR in
human lung cancer cells. Cancer Cell Int. 13:902013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Hu S, Zhang X, Wang L, Zhang X,
Yan B, Zhao J, Yang A and Zhang R: MicroRNA-7 arrests cell cycle in
G1 phase by directly targeting CCNE1 in human hepatocellular
carcinoma cells. Biochem Biophys Res Commun. 443:1078–1084. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okuda H, Xing F, Pandey PR, Sharma S,
Watabe M, Pai SK, Mo YY, Iiizumi-Gairani M, Hirota S, Liu Y, et al:
miR-7 suppresses brain metastasis of breast cancer stem-like cells
by modulating KLF4. Cancer Res. 73:1434–1444. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, et
al: microRNA-7 inhibits the epidermal growth factor receptor and
the Akt pathway and is down-regulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Zheng Y, Sun G and Xiong S:
Restoration of miR-7 expression suppresses the growth of Lewis lung
cancer cells by modulating epidermal growth factor receptor
signaling. Oncol Rep. 32:2511–2516. 2014.PubMed/NCBI
|
|
25
|
Liu R, Liu X, Zheng Y, Gu J, Xiong S,
Jiang P, Jiang X, Huang E, Yang Y, Ge D, et al: MicroRNA-7
sensitizes non-small cell lung cancer cells to paclitaxel. Oncol
Lett. 8:2193–2200. 2014.PubMed/NCBI
|
|
26
|
Meza-Sosa KF, Pérez-García EI,
Camacho-Concha N, López-Gutiérrez O, Pedraza-Alva G and
Pérez-Martínez L: miR-7 promotes epithelial cell transformation by
targeting the tumor suppressor KLF4. PLoS One. 9:e1039872014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ben Gacem R, Ben Abdelkrim O, Ziadi S, Ben
Dhiab M and Trimeche M: Methylation of miR-124a-1, miR-124a-2 and
miR-124a-3 genes correlates with aggressive and advanced breast
cancer disease. Tumour Biol. 35:4047–4056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fiaschetti G, Abela L, Nonoguchi N, Dubuc
AM, Remke M, Boro A, Grunder E, Siler U, Ohgaki H, Taylor MD, et
al: Epigenetic silencing of miRNA-9 is associated with HES1
oncogenic activity and poor prognosis of medulloblastoma. Br J
Cancer. 110:636–647. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Singh S, Chitkara D, Kumar V, Behrman SW
and Mahato RI: miRNA profiling in pancreatic cancer and restoration
of chemosensitivity. Cancer Lett. 334:211–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kitano M, Rahbari R, Patterson EE, Xiong
Y, Prasad NB, Wang Y, Zeiger MA and Kebebew E: Expression profiling
of difficult-to-diagnose thyroid histologic subtypes shows distinct
expression profiles and identify candidate diagnostic microRNAs.
Ann Surg Oncol. 18:3443–3452. 2011. View Article : Google Scholar : PubMed/NCBI
|
